IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

IDEXX Laboratories Inc. (NASDAQ:IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday.The animal health company reported fourth-quarter 2025 earnings of $3.08 per share, up 18% year over year, beating the consensus of $2.94. Comparable earnings were $2.92 per share. The company reported sales of $1.091 billion, beating the consensus of $1.073 billion, up 14% on a reported and 12% on an organic basis.“We enter 2026 with an exciting innovation pipelin ...